Similarly, a paper by Sasikumar et al. [21] investigated the role of [68Ga]Ga-PSMA-11 PET/CT for the assessment of patients harboring neoplasms in a cohort of 118 subjects with suspected PCa, revealing that it could act as a gate-keeper for the selection of patients who should undergo immediate deeper clinical investigations or could be kept on AS. The gene discussed is FOLH1; the disease is neoplasm.